Explore

Rapid Read Rapid Read
FDA Announces Recall of Nearly 12 Million Rohto Eye Drops Over Sterility Concerns

FDA Announces Recall of Nearly 12 Million Rohto Eye Drops Over Sterility Concerns

The Food and Drug Administration (FDA) has announced a recall of nearly 12 million bottles of Rohto eye drops due to concerns over their sterility. The recall, initiated by Vietnam-based Rohto-Mentholatum, affects products marketed for relieving redness, dryness, and eye strain. The FDA's enforcement report indicates that the recall involves 11,960,623 cartons of Rohto Cooling Eye Drops distributed across the United States. The recall was prompted by a 'lack of assurance of sterility,' meaning the eye drops may not be free from potentially harmful microorganisms. The affected products include various Rohto Cooling Eye Drops such as ALL-IN-ONE, Max Strength, Optic Glow, Digi Eye, Dry Aid, and Cool Relief, available in single and twin-pack configurations. These products have expiration dates ranging from July 2025 to February 2029. Consumers are advised to check the lot number and expiration date on their packaging against the manufacturer's recall notice or the FDA's website to determine if their product is...
Rapid Read Rapid Read
U.S. Trial Demonstrates Effectiveness of Low-Cost Liquid in Halting Children's Cavities Without Drilling

U.S. Trial Demonstrates Effectiveness of Low-Cost Liquid in Halting Children's Cavities Without Drilling

A major U.S. clinical trial has shown that silver diamine fluoride (SDF), a low-cost liquid, can effectively stop the progression of cavities in children without the need for drilling or anesthesia. Conducted by the University of Michigan School of Dentistry, the trial involved 830 children under six years old and demonstrated that applying SDF every six months could arrest decay in over half of the affected baby teeth. This treatment offers a non-invasive alternative to traditional methods, which often involve removing decayed material and filling the cavity. The trial's findings, published in JAMA Pediatrics, provide strong evidence for the safety and efficacy of SDF, potentially paving the way for FDA approval.
Rapid Read Rapid Read
FDA Regulates Sunscreen Safety Amidst 'Nontoxic' Marketing Claims

FDA Regulates Sunscreen Safety Amidst 'Nontoxic' Marketing Claims

The U.S. Food and Drug Administration (FDA) regulates sunscreens as over-the-counter drugs due to their health claims, such as preventing sunburn and reducing the risk of skin cancer and premature aging. Despite the marketing of sunscreens as 'nontoxic,' 'clean,' or 'natural,' these terms are not legally defined in the U.S., allowing brands to use them without meeting specific standards. The FDA evaluates sunscreen ingredients based on the 'generally recognized as safe and effective' (Grase) standard. Currently, only zinc oxide, titanium dioxide, and bemotrizinol are considered Grase. Dermatologists emphasize the importance of using sunscreen to protect against UV radiation, which is a significant risk factor for skin cancer.
Rapid Read Rapid Read
Rohto Cooling Eye Drops Recalled Nationwide Over Sterility Concerns

Rohto Cooling Eye Drops Recalled Nationwide Over Sterility Concerns

A recall has been initiated for over 11 million cartons of Rohto Cooling Eye Drops due to sterility concerns. The recall affects eight varieties of the product, including ALL-IN-ONE, Max Strength, and Optic Glow, with expiration dates from July 2026 to February 2029. These products, manufactured by Rohto-Mentholatum in Vietnam and distributed by The Mentholatum Company in New York, were recalled after the FDA identified a lack of assurance of sterility, which could pose a risk of contamination by harmful microbes. The FDA has classified this as a Class II recall, indicating that the use of these products may cause temporary or reversible health effects but are unlikely to result in serious consequences. Consumers are advised to stop using the affected products and can return them for a full refund.
Rapid Read Rapid Read
U.S. Trial Finds Low-Cost Liquid Effective in Preventing Children's Cavities

U.S. Trial Finds Low-Cost Liquid Effective in Preventing Children's Cavities

A major U.S. clinical trial has demonstrated that silver diamine fluoride (SDF), a low-cost liquid, can effectively halt the progression of cavities in children without the need for drilling or anesthesia. Conducted by the University of Michigan School of Dentistry, the trial involved 830 children under six years old and showed that applying SDF every six months successfully arrested decay in over half of the affected teeth. The findings, published in JAMA Pediatrics, suggest that SDF could become a widely used treatment, pending FDA approval, offering a non-invasive alternative to traditional cavity treatments.
Rapid Read Rapid Read
FDA and CDC Investigate E. coli Outbreak Linked to Recalled GreenWise Frozen Berries

FDA and CDC Investigate E. coli Outbreak Linked to Recalled GreenWise Frozen Berries

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are investigating a multistate E. coli outbreak linked to GreenWise organic frozen blueberries sold at Publix stores. The recall affects products distributed in Alabama, Florida, Georgia, Kentucky, North Carolina, South Carolina, Tennessee, and Virginia. The FDA has identified 12 illnesses, including four hospitalizations, associated with the outbreak. The contamination has been traced to organic frozen blueberries produced by Frutas y Hortalizas del Sur S.A. in Chile. The FDA has placed an import alert on the company's frozen blueberries, allowing future shipments to be detained while the investigation continues.
Rapid Read Rapid Read
FDA Expands Frozen Blueberry Recall Due to E. Coli Outbreak Affecting Multiple States

FDA Expands Frozen Blueberry Recall Due to E. Coli Outbreak Affecting Multiple States

The Food and Drug Administration (FDA) has expanded a recall on GreenWise Organic frozen blueberries and mixed berries due to potential contamination with Shiga toxin-producing E. coli O145:H28. This recall affects products sold in eight southeastern states, including Alabama, Florida, Georgia, Kentucky, North Carolina, South Carolina, Tennessee, and Virginia. The contamination has resulted in 12 confirmed illnesses, with four individuals requiring hospitalization. The FDA has identified specific lot codes and UPC numbers for the affected products, advising consumers to discard the berries or return them to Publix for a refund. Symptoms of E. coli infection include severe stomach cramps, diarrhea, and vomiting, and consumers experiencing these symptoms are urged to seek medical attention.
Rapid Read Rapid Read
Cyclospora Outbreak Affects 45 States, Linked to Contaminated Lettuce

Cyclospora Outbreak Affects 45 States, Linked to Contaminated Lettuce

A significant outbreak of cyclosporiasis, caused by the Cyclospora parasite, has affected approximately 18,000 individuals across 45 states in the U.S. The outbreak, which began in May, has been linked to contaminated shredded lettuce, particularly iceberg lettuce served at Taco Bell. The supplier, Taylor Farms, has issued a recall of its iceberg lettuce sourced from central Mexico. The outbreak has led to over 423 hospitalizations, though no deaths have been reported. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are investigating the outbreak, which has expanded to nine states in the Midwest. Health officials are also exploring other potential sources of contamination, including fresh parsley and cilantro.
Rapid Read Rapid Read
FDA Panel Recommends Broader Access to Peptide Therapies Despite Safety Concerns

FDA Panel Recommends Broader Access to Peptide Therapies Despite Safety Concerns

A federal advisory panel has recommended that the Food and Drug Administration (FDA) reclassify several peptide therapies, potentially allowing specialized pharmacies in the U.S. to offer them. The panel's decision, made during a two-day meeting, supports the use of peptides for various health benefits, despite the lack of large, well-controlled human trials. The peptides under consideration include BPC-157, MOTS-c, KPV, TB-500, Epitalon, and Semax, with Emideltide being the only one not endorsed. The FDA typically follows advisory committee recommendations, although it is not required to do so.
USA Today USA Today
Millions of eye drops recalled. See list of affected products

Millions of eye drops recalled. See list of affected products

The eye drops could cause adverse health effects if used, according to the FDA.
Trendline Trendline
FDA Panel Recommends Loosening Regulations on Peptides Amidst Rising Popularity

FDA Panel Recommends Loosening Regulations on Peptides Amidst Rising Popularity

FDA Panel Recommends Loosening Regulations on Peptides Amidst Rising Popularity
Rapid Read Rapid Read
FDA Considers New Guidelines as Study Reveals High Levels of Ultra-Processed Foods in U.S. Toddler Diets

FDA Considers New Guidelines as Study Reveals High Levels of Ultra-Processed Foods in U.S. Toddler Diets

A recent study presented at the Nutrition 2026 meeting by the American Society for Nutrition has revealed that four out of five foods sold for toddlers in the U.S. are ultra-processed. The study analyzed 2,783 products and found that 81% were classified as ultra-processed, with many failing to meet nutritional benchmarks set by the World Health Organization. Specifically, 17% of products failed for sugar content, 25% for sodium, 11% for fat, and 12% for energy density. The U.S. Food and Drug Administration (FDA) is considering implementing new guidelines for nutrition labels and marketing of food products to children, as the U.S. currently lacks mandatory warning labels for foods high in sugar, sodium, or calories. The study highlights the need for parents to be vigilant about checking labels and ingredients to ensure the nutritional quality of toddler foods.